NAMSDL is a 501(c)(3) nonprofit organization dedicated to comprehensive, integrative and effective state drug laws, policies and programs
Highlighted Issues

The Highlighted Issues content focuses on current, important and relevant state, national and world issues and NAMSDL’s intent to synthesize and evaluate information and present it in an informed manner.

 

This guidance explains FDA’s current thinking about the studies that should be conducted to demonstrate that a given formulation has abuse-deterrent properties. The guidance makes recommendations about how those studies should be performed and evaluated and discusses how to describe those studies and their implications in product labeling. Read more »

 

Additional Support Needed for Public Awareness Initiatives Read more »

 

NAMSDL details many elements of the new DEA controlled substance return and disposal regulations and looks at several state and locality programs currently in existence. Read more »

 

A recently released report by the Office of National Drug Control Policy (ONDCP) on the scope and nature of “doctor shopping” in the United States demonstrates a geographically widespread reduction in the behavior. Read more »

 

On September 9, 2014, the Clinton Foundation and the Johns Hopkins Bloomberg School of Public Health released a consensus statement that focused on prescription drug misuse, abuse and addiction. Read more »

PREV 1 2 3 4 5 6 7 NEXT